Btrone-S 1.5 Injection
Marketer
Bi-Cure Remedies
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Btrone-S 1.5 Injection
Combiflox 1.5 Injection is a dual-action antibiotic indicated for diverse bacterial infections. Its mechanism combats microbial proliferation, halting infection progression. Administration must be strictly under a physician's guidance; adherence to the prescribed schedule is crucial for optimal results. Complete the entire treatment course, even with symptom improvement, as premature cessation can compromise efficacy. Minor side effects may include nausea, vomiting, diarrhea, or dyspepsia. Report worsening symptoms immediately to your doctor. Seek immediate medical attention for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your doctor of all current medications, particularly if you are pregnant, breastfeeding, or have pre-existing conditions. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, avoid driving if drowsiness or dizziness occur. Adequate rest, nutrition, and hydration will support recovery. Your physician might order lab tests to monitor treatment response.
Primary Ingredients of Btrone-S 1.5 Injection
No text provided. Please provide the text you wish to be rewritten.
Uses of Btrone-S 1.5 Injection
Infections caused by bacteria
Major Benefits of Btrone-S 1.5 Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Btrone-S 1.5 Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Btrone-S 1.5 Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Btrone-S 1.5 Injection works:
Ceftriaxone and Sulbactam, the components of Btrone-S 1.5 Injection, act synergistically. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering bacterial survival. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thus optimizing Ceftriaxone's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
Btrone-S 1.5 Injection does not interact adversely with alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Btrone-S 1.5 is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
The administration of Btrone-S 1.5 Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding throughout their treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Administering Btrone-S 1.5 Injection might induce drowsiness, blurred vision, or dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Btrone-S 1.5 Injection to individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should receive Btrone-S 1.5 Injection cautiously, with potential dosage modification as determined by their physician. Dosage alteration of Btrone-S 1.5 Injection is unnecessary for individuals with mild or moderate liver dysfunction. Medical consultation is advised.
What if you forget to take Btrone-S 1.5 Injection :
Omitting a scheduled dose of Btrone-S 1.5 Injection warrants immediate physician consultation.
Facts to Know About Btrone-S 1.5 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |


